The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...

Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results ...

Zealand Pharma A/S (ZLDPF) shares ended the last trading session 8% higher at $72.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Douglas Pharmaceuticals, New Zealand’s largest privately owned pharmaceutical company, announces the launch of Winlevi® ...

Complete Zealand Pharma A/S stock information by Barron's. View real-time ZLDPF stock price and news, along with industry-best analysis.

Copenhagen, Denmark Saturday, April 26, 2025, 18:00 Hrs [IST] ...

Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or ...

Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.

Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery Utpal ...

Zealand Pharma hires Eli Lilly veteran Utpal Singh as CSO to advance peptide platform, following Roche obesity drug deal and ...

Company announcement - No. 9 / 2025 Zealand Pharma launches long-term incentive programs for Zealand Pharma's Board of Directors, Corporate Management and employees for 2025 Copenhagen, Denmark, April ...

Young salmon in central Sweden must endure a gauntlet to migrate from their freshwater spawning grounds to the Baltic Sea. Their 28-km route along the Dal River is rife with danger, from northern pike ...